Observational Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Oct 15, 2022; 14(10): 2025-2037
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.2025
Table 1 Patients’ baseline characteristics, n = 203
Characteristic
Total
Colorectal, n = 101
Non-colorectal digestive cancer, n = 102
P value
λ
n
%
n
%
n
%
Sex0.6220.026
Men11556.76059.45553.9
Women8843.34140.64746.1
Age0.0280.081
≤ 65 yr8541.95049.53534.3
> 65 yr11859.15150.56765.7
Number of Elixhauser comorbidities (%)0.3440.033
≤ 48139.93736.64443.1
> 412260.16463.45856.9
ECOG0.0290.086
05627.63534.72120.6
113868.06261.47674.5
294.444.054.9
Marital status0.8830.001
Married/partnered16786.68786.29287.0
Not partnered3613.42413.82413.0
Children0.3700.029
Do not have children3517.21514.92019.6
Have children16882.88685.18281.4
Educational level0.5210.010
Primary 11255.25857.45452.9
High school or higher 9144.84342.64847.1
Histology0.0010.129
Adenocarcinoma18088.79897.08280.4
Others2311.333.02019.6
Metastasis0.0010.218
Locally advanced 3215.811.03130.4
Metastatic disease 17184.210099.07169.6
Biomarker0.0010.196
No16179.36665.39593.1
Yes4220.73534.776.9
Estimated survival 0.0010.776
< 18 mo10853.21413.99492.2
≥ 18 mo954.88786.187.8
Treatment modality0.0010.339
Chemotherapy13968.54544.69492.2
Combined 6431.55654.487.8